
Data Driven Studies: Fusion is Axiom’s proprietary, easy-to-use and cost-effective eClinical solution that is focused on small to medium sized device, pharma, and biotech companies.
Over 15 fully integrated modules that connect seamlessly in one unified platform – accessible with a single sign-on.
Axiom offers the following training material(s) available for the JENAVALVE – JENA-VAD study:

JenaValve is a global medical device company dedicated to supporting physicians, by developing innovative medical device technology that conclusively addresses the needs of patients with structural heart disease.
JENA-VAD focuses on the evaluation of the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous-flow left ventricular assist devices and clinically significant aortic regurgitation who are indicated for TAVR.